Rifkind R A, Marks P A, Bank A, Terada M, Reuben R C, Maniatis G M, Fibach E, Nudel U, Salmon J E, Gazitt Y
In Vitro. 1978 Jan;14(1):155-61. doi: 10.1007/BF02618182.
Studies are described employing two erythropoietic systems to elucidate regulatory mechanisms that control both normal erythropoiesis and erythroid differentiation of transformed hemopoietic precursors. Evidence is provided suggesting that normal erythroid cell precursors require erythropoietin as a growth factor that regulates the number of precursors capable of differentiating. Murine erythroleukemia cells proliferate without need of erythropoietin; they show a variable, generally low, rate of spontaneous differentiation and a brisk rate of erythropoiesis in response to a variety of chemical agents. Present studies suggest that these chemical inducers initiate a series of events including cell surface related changes, alterations in cell cycle kinetics, and modifications of chromatin and DNA structure which result in the irreversible commitment of these leukemia cells to erythroid differentiation and the synthesis of red-cell-specific products.
本文描述了利用两种红细胞生成系统来阐明控制正常红细胞生成和转化造血前体细胞红系分化的调节机制的研究。有证据表明,正常红系细胞前体需要促红细胞生成素作为一种生长因子,来调节能够分化的前体细胞数量。小鼠红白血病细胞增殖不需要促红细胞生成素;它们表现出可变的、通常较低的自发分化率,以及对多种化学试剂快速的红细胞生成率。目前的研究表明,这些化学诱导剂引发了一系列事件,包括细胞表面相关变化、细胞周期动力学改变以及染色质和DNA结构修饰,这些事件导致这些白血病细胞不可逆地定向于红系分化并合成红细胞特异性产物。